17th Annual World Preclinical Congress - Boston, MA (18th-21st June) - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.

aProximateTM

Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Published 15th June 2018 | Uncategorised

17th Annual World Preclinical Congress – Boston, MA (18th-21st June)

Dr Colin Brown will be attending the 17th Annual World Preclinical Congress between 18th and 21st June in Boston.

Dr Brown is the developer of the aProximateTM assay for measuring kidney transporter and nephrotoxicity licensed exclusively to Newcells Biotech.

The World Preclinical Congress is a key networking event focusing on the latest trends and technologies impacting drug discovery and translational research.

Dr Brown will be meeting with partners with research interests in renal, hepatic and GI drug transporters. If you are attending the World Preclinical Congress and would like to arrange a meeting with Dr Brown, then please let us know – Contact Us  

 

Share This:
Tweet Post Share